MCID: MNN006
MIFTS: 42

Meninges Hemangiopericytoma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Meninges Hemangiopericytoma

Aliases & Descriptions for Meninges Hemangiopericytoma:

Name: Meninges Hemangiopericytoma 12 14
Hemangiopericytoma of Meninges 12 69
Meningeal Hemangiopericytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4957
NCIt 47 C4660
SNOMED-CT 64 277522009
UMLS 69 C0349622

Summaries for Meninges Hemangiopericytoma

MalaCards based summary : Meninges Hemangiopericytoma, also known as hemangiopericytoma of meninges, is related to meningitis and anal gland neoplasm. An important gene associated with Meninges Hemangiopericytoma is STAT6 (Signal Transducer And Activator Of Transcription 6), and among its related pathways/superpathways are Development IGF-1 receptor signaling and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Doxorubicin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and lung, and related phenotypes are cellular and growth/size/body region

Related Diseases for Meninges Hemangiopericytoma

Diseases related to Meninges Hemangiopericytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 64)
id Related Disease Score Top Affiliating Genes
1 meningitis 10.5
2 anal gland neoplasm 10.3 HEY1 NCOA2 VIM
3 sohval soffer syndrome 10.2 IGF1 IGFBP3
4 epileptic encephalopathy, early infantile, 24 10.2 IGF1 IGF2 IGFBP3
5 chest wall parachordoma 10.2 CD34 VIM
6 fallopian tube teratoma 10.2 CD34 IGF1
7 pleomorphic adenoma 10.2 CD34 HBA1
8 basophil adenoma 10.2 CD34 HBA1
9 spontaneous tension pneumothorax 10.2 CD34 IGF1
10 ovarian lymphoma 10.1 CD34 HBA1
11 alcohol-induced mental disorder 10.1 CD34 HBA1 VIM
12 sarcocystosis 10.1 CD34 HBA1
13 ossifying fibromyxoid tumor 10.1 CD34 HBA1 VIM
14 dermoid cyst 10.1 CD34 HBA1
15 neurilemmoma of the pleura 10.1 GFAP HBA1 PLAUR
16 seow najjar syndrome 10.1 IGF1 IGFBP3 INS
17 diarrhea, chronic, with villous atrophy 10.1 HBA1 IGF2 NAB2 STAT6 VIM
18 jewett-marshall bladder cancer 10.1 CD34 HBA1 VIM
19 cervix endometrial stromal tumor 10.1 CD34 HBA1
20 hyperpituitarism 10.1 CD34 HBA1 VIM
21 diarrhea 3, secretory sodium, congenital, syndromic 10.1 IGF1 IGFBP3 INS
22 hyperinsulinemic hypoglycemia, familial, 5 10.1 IGF1 IGFBP3 INS
23 protein s deficiency 10.1 IGF1 IGFBP3 INS
24 acantholytic squamous cell skin carcinoma 10.1 CD34 CSF1R IGF2
25 brucella canis brucellosis 10.1 IGF1 IGF2 INS
26 neurogenic arthropathy 10.1 IGF1 IGF2 INS
27 argininosuccinic aciduria 10.1 IGF1 IGF2 IGFBP3
28 heavy chain disease 10.0 CD34 GFAP HBA1
29 chondroma 10.0 IGF1 IGF2 INS
30 thyroid angiosarcoma 10.0 CD34 F8 HBA1
31 breast squamous cell carcinoma 10.0 CD34 EPB41L3 GFAP VIM
32 phencyclidine abuse 10.0 CD34 F8 HBA1
33 bilateral breast cancer 10.0 CD34 F8 HBA1
34 cervix squamous papilloma 10.0 IGF1 IGFBP3 INS
35 leiomyomatosis 10.0 CD34 GFAP
36 vulvar dystrophy 10.0 CD34 HBA1 INS
37 fetal warfarin syndrome 10.0 IGF1 IGF2 IGFBP3 INS
38 renal adenoma 10.0 CD34 F8 HBA1
39 microinvasive cervical squamous cell carcinoma 10.0 CHGA GFAP VIM
40 thrombophilia 10.0 IGF1 IGF2 IGFBP3 INS
41 endometrial stromal sarcoma 10.0 CHGA GFAP VIM
42 vernal conjunctivitis 10.0 HBA1 IGF1 INS
43 edict syndrome 10.0 IGF1 IGF2 IGFBP3 INS
44 hypoglycemia 10.0
45 black piedra 10.0 CD34 IGF2 VIM
46 calcific tendinitis 10.0 CHGA GFAP VIM
47 external ear disease 10.0 F8 GFAP TERT
48 brain stem ependymoma 9.9 CHGA GFAP
49 hepatitis 9.9
50 growth retardation hydrocephaly lung hypoplasia 9.9 CHGA INS VIM

Graphical network of the top 20 diseases related to Meninges Hemangiopericytoma:



Diseases related to Meninges Hemangiopericytoma

Symptoms & Phenotypes for Meninges Hemangiopericytoma

MGI Mouse Phenotypes related to Meninges Hemangiopericytoma:

44 (show all 14)
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.43 GFAP HEY1 IGF1 IGF2 INS LIG3
2 growth/size/body region MP:0005378 10.37 GFAP HEY1 IGF1 IGF2 IGFBP3 INS
3 behavior/neurological MP:0005386 10.35 CACNA1A CSF1R EPB41L3 GFAP IGF2 IGFBP3
4 homeostasis/metabolism MP:0005376 10.33 CACNA1A CD34 IGF1 IGF2 IGFBP3 INS
5 endocrine/exocrine gland MP:0005379 10.25 INS NCOA2 STAT6 TERT CACNA1A CHGA
6 immune system MP:0005387 10.25 CACNA1A CD34 CSF1R F8 GFAP IGF1
7 mortality/aging MP:0010768 10.24 CACNA1A CHGA CSF1R EPB41L3 F8 GFAP
8 hematopoietic system MP:0005397 10.22 CACNA1A CD34 CSF1R F8 IGF1 IGF2
9 integument MP:0010771 10.1 CACNA1A CD34 CSF1R IGF1 IGF2 IGFBP3
10 nervous system MP:0003631 10.07 CACNA1A CSF1R EPB41L3 GFAP HEY1 IGF1
11 muscle MP:0005369 10.02 CACNA1A GFAP HEY1 IGF1 IGF2 IGFBP3
12 normal MP:0002873 9.81 CACNA1A CSF1R EPB41L3 GFAP HEY1 IGF1
13 reproductive system MP:0005389 9.77 CACNA1A CHGA CSF1R EPB41L3 F8 IGF1
14 respiratory system MP:0005388 9.23 IGF1 IGF2 NAB2 PLAUR STAT6 TERT

Drugs & Therapeutics for Meninges Hemangiopericytoma

Drugs for Meninges Hemangiopericytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 133)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
4
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
5
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
6
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
7
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
8
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
9
Lenograstim Approved Phase 3,Phase 2 135968-09-1
10
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
11
Dactinomycin Approved Phase 3,Phase 2 50-76-0 2019 457193
12
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
13
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
14
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
15 Alkylating Agents Phase 3,Phase 2,Phase 1
16 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
17 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
18 Isophosphamide mustard Phase 3,Phase 2,Phase 1
19 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
20 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
21 pancreatic polypeptide Phase 3,Phase 1
22 Analgesics Phase 3,Phase 1
23 Cholinergic Agents Phase 3,Phase 2
24 Adjuvants, Anesthesia Phase 3
25 Cholinesterase Inhibitors Phase 3,Phase 2
26 Narcotics Phase 3
27 Neurotransmitter Agents Phase 3,Phase 2
28 Nootropic Agents Phase 3,Phase 2
29 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
30 Analgesics, Opioid Phase 3
31 Anesthetics Phase 3
32 Anesthetics, General Phase 3
33 Anesthetics, Intravenous Phase 3
34 Peripheral Nervous System Agents Phase 3,Phase 1
35 Etoposide phosphate Phase 3,Phase 2
36 Anti-Infective Agents Phase 3,Phase 2,Phase 1
37 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
38 Liver Extracts Phase 3,Phase 1
39 Antimitotic Agents Phase 3,Phase 2,Phase 1
40 Antirheumatic Agents Phase 3,Phase 2,Phase 1
41 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
42 Central Nervous System Depressants Phase 3
43 Cola Nutraceutical Phase 3,Phase 1
44
Dacarbazine Approved, Investigational Phase 2,Phase 1 4342-03-4 5351166
45
Temozolomide Approved, Investigational Phase 2,Phase 1 85622-93-1 5394
46
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
47
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
48
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
49
Bevacizumab Approved, Investigational Phase 2 216974-75-3
50
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062

Interventional clinical trials:

(show top 50) (show all 61)
id Name Status NCT ID Phase
1 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Unknown status NCT00346164 Phase 3
2 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3
3 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
4 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3
5 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3
6 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3
7 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3
8 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3
9 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
10 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3
11 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2
12 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2
13 Imatinib Mesylate in Treating Patients With Recurrent Meningioma Completed NCT00045734 Phase 2
14 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2
15 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2
16 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2
17 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2
18 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2
19 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2
20 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2
21 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2
22 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2
23 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2
24 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2
25 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2
26 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Completed NCT00025675 Phase 2
27 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2
28 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2
29 Proton Radiation For Meningiomas and Hemangiopericytomas Recruiting NCT01117844 Phase 1, Phase 2
30 Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Recruiting NCT01532687 Phase 2
31 Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes Recruiting NCT02815995 Phase 2
32 Trial of Dasatinib in Advanced Sarcomas Active, not recruiting NCT00464620 Phase 2
33 Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas Active, not recruiting NCT01125046 Phase 2
34 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Active, not recruiting NCT01024907 Phase 1, Phase 2
35 A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma Not yet recruiting NCT03016091 Phase 2
36 Phase II Pediatric Study With Dabrafenib in HGG Patients Not yet recruiting NCT02684058 Phase 2
37 S9624 Ifosfamide in Treating Patients With Meningeal Tumors Terminated NCT00003292 Phase 2
38 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
39 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1
40 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Gluco Completed NCT01082926 Phase 1
41 Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Completed NCT00720174 Phase 1
42 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1
43 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1
44 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
45 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1
46 CC-5013 in Treating Patients With Recurrent Glioma Completed NCT00036894 Phase 1
47 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1
48 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1
49 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1
50 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1

Search NIH Clinical Center for Meninges Hemangiopericytoma

Genetic Tests for Meninges Hemangiopericytoma

Anatomical Context for Meninges Hemangiopericytoma

MalaCards organs/tissues related to Meninges Hemangiopericytoma:

39
Bone, Liver, Lung, Heart, Adrenal Gland

Publications for Meninges Hemangiopericytoma

Articles related to Meninges Hemangiopericytoma:

(show all 49)
id Title Authors Year
1
NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor. ( 26883114 )
2016
2
Gastric metastasis from malignant meningeal hemangiopericytoma. ( 27801496 )
2016
3
Meningeal Hemangiopericytoma in 33-Year-Old Female; a Case Report. ( 27799979 )
2016
4
Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases. ( 27044772 )
2016
5
Intracranial meningeal hemangiopericytoma: Recurrences at the initial and distant intracranial sites and extraneural metastases to multiple organs. ( 26171177 )
2015
6
Liver metastases from meningeal hemangiopericytoma. ( 25913235 )
2015
7
Living-Donor Liver Transplantation for Hepatic Metastasis FromA Meningeal Hemangiopericytoma: A Case Report. ( 26361698 )
2015
8
Meningeal hemangiopericytoma only diagnosed at the time of late bone metastasis. ( 24934329 )
2014
9
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. ( 23575898 )
2013
10
Metastasis of intracranial meningeal hemangiopericytoma to thoracic spine 17A years after surgical excision: a case report. ( 23943153 )
2013
11
Optic nerve meningeal hemangiopericytoma: a clinicopathologic case report. ( 23294915 )
2013
12
Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion. ( 24124145 )
2013
13
The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database. ( 22867893 )
2013
14
MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma. ( 22824994 )
2012
15
Meningeal Hemangiopericytoma with Intracranial Metastases in an HIV-Positive Male: Case Report and Review of the Literature. ( 22666206 )
2012
16
Intracranial meningeal hemangiopericytoma: 10A years experience of a tertiary care Institute. ( 22790838 )
2012
17
Intracranial meningeal hemangiopericytoma metastatic to the scapula. ( 22229602 )
2012
18
Recurrent meningeal hemangiopericytoma with multiple metastasis and hypoglycemia: a case report. ( 23024657 )
2012
19
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma. ( 21558077 )
2011
20
The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution. ( 21667225 )
2011
21
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma. ( 20622667 )
2010
22
Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. ( 20165866 )
2010
23
Multiple metastatic progression of meningeal hemangiopericytoma initially diagnosed as atypical meningioma with temporal bone invasion. ( 19201308 )
2009
24
Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy. ( 18459177 )
2008
25
Meningeal hemangiopericytoma manifesting as massive intracranial hemorrhage--two case reports. ( 16498220 )
2006
26
Bone metastasis of intracranial meningeal hemangiopericytoma. ( 15990973 )
2005
27
Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report. ( 15143990 )
2004
28
Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. ( 15668900 )
2004
29
[Multiple extracranial metastases from a meningeal hemangiopericytoma and severe hypoglycemia: a case report]. ( 15227844 )
2004
30
Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. ( 15042684 )
2004
31
Meningeal hemangiopericytoma with delayed multiple distant metastases. ( 15648288 )
2004
32
Fine needle aspiration cytology of hepatic metastasis from a meningeal hemangiopericytoma. A case report. ( 12685202 )
2003
33
Fetal meningeal hemangiopericytoma. Case report. ( 12450048 )
2002
34
Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. ( 11773263 )
2001
35
Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. ( 11322435 )
2001
36
Tc-99m MDP and Tl-201 scintigraphy in a case of metastatic meningeal hemangiopericytoma. ( 11711721 )
2001
37
Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma. ( 11266526 )
2001
38
Meningeal hemangiopericytoma in childhood. ( 11003400 )
2000
39
[Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports]. ( 11084416 )
2000
40
Pancreatic head mass from metastatic meningeal hemangiopericytoma. ( 18521297 )
2000
41
Hepatic and pulmonary metastases from a meningeal hemangiopericytoma and severe hypoglycemia due to abnormal secretion of insulin-like growth factor: a case report. ( 10326704 )
1999
42
Management of recurrent meningeal hemangiopericytoma. ( 9587125 )
1998
43
Metastatic meningeal hemangiopericytoma of thoracic spine. ( 9822848 )
1998
44
Radiotherapy of bone metastases of a spinal meningeal hemangiopericytoma. ( 9581183 )
1998
45
The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. ( 9351573 )
1997
46
Meningeal hemangiopericytoma metastatic to the heart. ( 8776772 )
1996
47
The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma. ( 8858518 )
1996
48
Insulin-like growth factor II expression in primary meningeal hemangiopericytoma and its metastasis to the liver accompanied by hypoglycemia. ( 8760024 )
1996
49
Soft-tissue and meningeal hemangiopericytomas: an immunohistochemical and ultrastructural study. ( 2318483 )
1990

Variations for Meninges Hemangiopericytoma

Expression for Meninges Hemangiopericytoma

Search GEO for disease gene expression data for Meninges Hemangiopericytoma.

Pathways for Meninges Hemangiopericytoma

GO Terms for Meninges Hemangiopericytoma

Cellular components related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.91 CD34 CHGA F8 HBA1 IGF1 IGF2
2 platelet alpha granule lumen GO:0031093 9.33 F8 IGF1 IGF2
3 insulin-like growth factor ternary complex GO:0042567 8.96 IGF1 IGFBP3
4 insulin-like growth factor binding protein complex GO:0016942 8.62 IGF1 IGFBP3

Biological processes related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.71 IGF1 IGF2 IGFBP3 INS
2 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.67 IGF1 IGF2 INS
3 movement of cell or subcellular component GO:0006928 9.61 IGF1 PLAUR VIM
4 glucose metabolic process GO:0006006 9.54 CACNA1A IGF2 INS
5 positive regulation of glycolytic process GO:0045821 9.51 IGF1 INS
6 positive regulation of insulin-like growth factor receptor signaling pathway GO:0043568 9.48 IGF1 IGFBP3
7 positive regulation of insulin receptor signaling pathway GO:0046628 9.46 IGF2 INS
8 positive regulation of glucose import GO:0046326 9.43 IGF1 INS TERT
9 positive regulation of mitotic nuclear division GO:0045840 9.33 IGF1 IGF2 INS
10 negative regulation of vasodilation GO:0045908 9.32 CHGA INS
11 positive regulation of MAPK cascade GO:0043410 9.26 IGF1 IGF2 IGFBP3 INS
12 positive regulation of glycogen biosynthetic process GO:0045725 8.8 IGF1 IGF2 INS

Molecular functions related to Meninges Hemangiopericytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 insulin receptor binding GO:0005158 9.13 IGF1 IGF2 INS
2 insulin-like growth factor receptor binding GO:0005159 8.8 IGF1 IGF2 INS
3 protein binding GO:0005515 10.09 CACNA1A EPB41L3 F8 GFAP HBA1 HEY1

Sources for Meninges Hemangiopericytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....